M&A Deal Summary

Sartorius Stedim Biotech Acquires Biohit - Liquid Handling Business

On October 26, 2011, Sartorius Stedim Biotech acquired medical products company Biohit - Liquid Handling Business from Biohit for 68M EUR

Acquisition Highlights
  • This is Sartorius Stedim Biotech’s 2nd transaction in the Medical Products sector.
  • This is Sartorius Stedim Biotech’s 6th largest (disclosed) transaction.
  • This is Sartorius Stedim Biotech’s 1st transaction in Finland.

M&A Deal Summary

Date 2011-10-26
Target Biohit - Liquid Handling Business
Sector Medical Products
Buyer(s) Sartorius Stedim Biotech
Sellers(s) Biohit
Deal Type Divestiture
Deal Value 68M EUR

Target

Biohit - Liquid Handling Business

Helsinki, Finland
Biohit - Liquid Handling Business is a provider of electronic and mechanical pipettes and dispensers, and disposable tips, as well as pipette maintenance and calibration services.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sartorius Stedim Biotech

Aubagne, France

Category Company
Founded 1870
Sector Internet Software and Services
Employees10,030
Revenue 2.8B EUR (2024)
DESCRIPTION

Sartorius Stedim Biotech is a provider of cutting edge products and services for the development, quality assurance and production processes of the biopharmaceutical industry. Sartorius Stedim Biotech was founded in 1870 and is based in Aubagne, France.


DEAL STATS #
Overall 2 of 19
Sector: Medical Products M&A 2 of 6
Type: Divestiture M&A Deals 1 of 4
Country: Finland M&A 1 of 1
Year: 2011 M&A 1 of 1
Size (of disclosed) 6 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-10-31 Wave Biotech AG

Tagelswangen, Switzerland

Wave Biotech AG is among the globally major companies for disposable bioreactors, which are an innovative alternative to traditional reusable stainless steel systems. These bioreactors are used by the biopharmaceutical industry to produce vaccines and monoclonal antibodies, for instance. Wave bioreactors have become quickly established on the market. They offer biopharmaceutical manufacturers countless advantages over conventional systems, such as more flexible process designing and significantly lower costs for cleaning and validation

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-16 TAP Biosystems

Royston, United Kingdom

TAP Biosystems Ltd. is a provider of automated cell culture and fermentation systems to the bio-pharma, regenerative medicine and industrial biotechnology sectors, focusing on: Bioprocess development, Cell therapy & stem cell research, GMP manufacture of biologics and Discovery research.

Buy $45M

Seller(S) 1

SELLER

Biohit

Helsinki, Finland

Category Company
Founded 1988
Sector Medical Products
Employees49
Revenue 14M EUR (2024)
DESCRIPTION

Biohit is a developer, manufacturer, and marketer of liquid handling products and diagnostic test systems for use in research, healthcare, and industrial laboratories. Liquid handling products include electronic and mechanical pipettes and dispensers, and disposable tips, as well as pipette maintenance and calibration services. Biohit was founded in 1988 and is based in Helsinki, Finland.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Finland M&A 1 of 1
Year: 2011 M&A 1 of 1
Size (of disclosed) 1 of 1